Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Vesicare – Oral Selective Muscarinic Receptor

Drug (Brand / Generic)

Vesicare (solifenacin succinate; YM905)

Company / Licensee

Yamanouchi Pharmaceutical

Therapy Class

Selective anticholinergic

Product Description

Oral selective muscarinic receptor antagonist

Current Indication

Urinary frequency, urgency and incontinence associated with OAB

Market Sector

Urology

Development Status

Launched in Europe, US and Japan
Expand
Close
Close
Close

Go Top